Ingevity Corp buy BMO Capital Markets
Start price
07.08.25
/
50%
€40.88
Target price
07.08.26
€53.17
Performance (%)
52.89%
Price
16.04.26
€62.00
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets for Ingevity Corp has seen massive gains of 52.89%. This prediction currently runs until 07.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -2.344% | -2.344% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat